Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of bio-based chemicals.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/28/14 | $48,000,000 |
BP Alternative Energy DSM Venturing Monitor Ventures Sime Darby Berhad | undisclosed |
